Gene ID 581
Formulation 50 µg (0.2 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 0.1% BSA and 0.02% thimerosal.
Antibody Target Bax
Shipping gel pack
Concentration 0.5 mg/ml
Storage Temp. -20 °C
Appearance Colorless liquid
Research Use For Rersearch Use Only! Not to be used in humans.
Shelf Life 1 year
Handling The peptide solution should be gently mixed before use.
Test You can block the antibody by the specific target amino acid sequence of peptide.
Properties blocking peptide
Description Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
Short name Bax Blocking Peptide
Technique blocking peptide, Blocking, peptide
Alternative name BCL2-associated X protein inhibiting short protein sequence
Alternative technique control
Alternative to gene target BCL2-associated X protein, BCL2L4, BAX and IDBG-61459 and ENSG00000087088 and 581, BH3 domain binding, nuclei, Bax and IDBG-183241 and ENSMUSG00000003873 and 12028, BAX and IDBG-640344 and ENSBTAG00000013340 and 100850136,280730